Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 2051 results found since Jan 2013.
Prevention of Shingles in Dermatology Patients on Systemic Medications
Skin Therapy Lett. 2023 Jul;28(4):4-6.ABSTRACTThe lifetime risk for herpes zoster (HZ) of approximately 1 in 3 is increased with advancing age, a family history of HZ, diseases with altered immune function, immunosuppression, physical trauma and psychological stress. In dermatology, monotherapy with current biologics does not increase risk, however systemic steroids, Janus kinase inhibitors and combination biologic/conventional disease-modifying antirheumatics do. The recombinant zoster vaccine (RZV, Shingrix®), an adjuvanted non-live subunit vaccine against the glycoprotein E subunit of varicella zoster virus, is approve...
Source: Skin Therapy Letter - July 13, 2023 Category: Dermatology Authors: Lyn Guenther Source Type: research
Herpes Zoster Infection in Atopic Patients Undergoing Upadacitinib: Practical Suggestions on Vaccination and Management
Dermatitis. 2023 Jul 11. doi: 10.1089/derm.2023.0088. Online ahead of print.NO ABSTRACTPMID:37428677 | DOI:10.1089/derm.2023.0088
Source: Dermatitis - July 10, 2023 Category: Dermatology Authors: Michela Ortoncelli Luca Mastorino Federica Gelato Irene Richiardi Giovanni Cavaliere Pietro Quaglino Simone Ribero Source Type: research
The incidence of herpes zoster in China: A meta-analysis and evidence quality assessment
Hum Vaccin Immunother. 2023 Aug 1;19(2):2228169. doi: 10.1080/21645515.2023.2228169. Epub 2023 Jul 9.ABSTRACTThis review aimed to estimate the disease burden of herpes zoster (HZ) in China and explore the application of the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach in studies of disease burden. We searched for the literature of observational studies analyzing HZ incidence in populations of all ages in China. Meta-analysis models were constructed to calculate the pooled incidence of HZ and pooled risks of postherpetic neuralgia (PHN), HZ recurrence, and hospitalization. Subgroup anal...
Source: Herpes - July 10, 2023 Category: Infectious Diseases Authors: Zhujiazi Zhang Xinnong Liu Luodan Suo Dan Zhao Jingbin Pan Li Lu Source Type: research
Herpes Zoster Infection in Atopic Patients Undergoing Upadacitinib: Practical Suggestions on Vaccination and Management
Dermatitis. 2023 Jul 11. doi: 10.1089/derm.2023.0088. Online ahead of print.NO ABSTRACTPMID:37428677 | DOI:10.1089/derm.2023.0088
Source: Dermatitis - July 10, 2023 Category: Dermatology Authors: Michela Ortoncelli Luca Mastorino Federica Gelato Irene Richiardi Giovanni Cavaliere Pietro Quaglino Simone Ribero Source Type: research
The incidence of herpes zoster in China: A meta-analysis and evidence quality assessment
Hum Vaccin Immunother. 2023 Jul 9:2228169. doi: 10.1080/21645515.2023.2228169. Online ahead of print.ABSTRACTThis review aimed to estimate the disease burden of herpes zoster (HZ) in China and explore the application of the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach in studies of disease burden. We searched for the literature of observational studies analyzing HZ incidence in populations of all ages in China. Meta-analysis models were constructed to calculate the pooled incidence of HZ and pooled risks of postherpetic neuralgia (PHN), HZ recurrence, and hospitalization. Subgroup anal...
Source: Herpes - July 10, 2023 Category: Infectious Diseases Authors: Zhujiazi Zhang Xinnong Liu Luodan Suo Dan Zhao Jingbin Pan Li Lu Source Type: research
